NCTWX
Price
$30.38
Change
-$0.16 (-0.52%)
Updated
Sep 18 closing price
Net Assets
918.54M
RPMGX
Price
$97.30
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
Interact to see
Advertisement

NCTWX vs RPMGX

NCTWX vs RPMGX Comparison Chart in %
View a ticker or compare two or three
VS
NCTWX vs. RPMGX commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCTWX is a Hold and RPMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 20.8B vs. NCTWX (919M). NCTWX pays higher dividends than RPMGX: NCTWX (0.07) vs RPMGX (0.00). NCTWX was incepted earlier than RPMGX: NCTWX (43 years) vs RPMGX (34 years). RPMGX (0.77) is less costly to investors than NCTWX (0.59). RPMGX is a more actively managed with annual turnover of: 31.50 vs. NCTWX (0.32). RPMGX has a lower initial minimum investment than NCTWX: RPMGX (2500) vs NCTWX (100000). RPMGX annual gain was more profitable for investors over the last year : -5.63 vs. NCTWX (-9.95). NCTWX return over 5 years is better than : -17.18 vs. RPMGX (-24.20).
NCTWXRPMGXNCTWX / RPMGX
Total Expense Ratio0.590.7777%
Annual Report Gross Expense Ratio0.590.7777%
Fund Existence43 years34 years-
Gain YTD3.7210.0626,031%
Front LoadN/AN/A-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets919M20.8B4%
Annual Yield % from dividends0.070.00-
Returns for 1 year-9.95-5.63177%
Returns for 3 years2.04-0.19-1,100%
Returns for 5 years-17.18-24.2071%
Returns for 10 years24.6427.7589%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOAX11.150.01
+0.09%
Goldman Sachs Mid Cap Growth A
JOHAX29.76-0.01
-0.03%
JOHCM International Select Investor
PRHSX94.44-0.31
-0.33%
T. Rowe Price Health Sciences
THMEX16.85-0.07
-0.41%
CCT Thematic Equity Institutional
BRSYX16.90-0.09
-0.53%
MFS Blended Research Small Cap Eq R6